Patents by Inventor Claire Legay

Claire Legay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING NEUROMUSCULAR JUNCTION-RELATED DISEASES
    Publication number: 20230115252
    Abstract: The present invention relates to methods for treating neuromuscular junction-related diseases. In particular, the present invention relates to a method of treating a neuromuscular junction-related disease in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one inhibitor of glycogen synthase kinase 3 (GSK3).
    Type: Application
    Filed: December 13, 2022
    Publication date: April 13, 2023
    Inventors: Laure STROCHLIC, Julien MESSEANT, Perrine DELERS, Alexandre DOBBERTIN, Claire LEGAY
  • METHODS FOR TREATING NEUROMUSCULAR JUNCTION-RELATED DISEASES
    Publication number: 20200323900
    Abstract: The present invention relates to methods for treating neuromuscular junction-related diseases. In particular, the present invention relates to a method of treating a neuromuscular junction-related disease in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one inhibitor of glycogen synthase kinase 3 (GSK3).
    Type: Application
    Filed: June 26, 2020
    Publication date: October 15, 2020
    Inventors: Laure Strochlic, Julien Messeant, Perrine Delers, Alexandre Dobbertin, Claire Legay
  • METHODS FOR TREATING NEUROMUSCULAR JUNCTION-RELATED DISEASES
    Publication number: 20170209488
    Abstract: The present invention relates to methods for treating neuromuscular junction-related diseases. In particular, the present invention relates to a method of treating a neuromuscular junction-related disease in a subject in need thereof comprising ad ministering the subject with a therapeutically effective amount of at least one inhibitor of glycogen synthase kinase 3 (GSK3).
    Type: Application
    Filed: July 16, 2015
    Publication date: July 27, 2017
    Inventors: Laure Strochlic, Julien Messeant, Perrine Delers, Alexandre Dobbertin, Claire Legay